SciSparc Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: IL0010951403
USD
1.74
-0.03 (-1.69%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

How big is SciSparc Ltd.?

22-Jun-2025

As of Jun 18, SciSparc Ltd. has a market capitalization of 3.40 million, categorizing it as a Micro Cap company, with net sales of 0.00 million and a net profit of -8.95 million over the latest four quarters.

Market Cap: As of Jun 18, SciSparc Ltd. has a market capitalization of 3.40 million, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, SciSparc Ltd. reported net sales of 0.00 million and a net profit of -8.95 million.<BR><BR>Balance Sheet Snapshot: As of Dec 24, the company has shareholder's funds amounting to 8.15 million and total assets of 10.35 million.

Read More

What does SciSparc Ltd. do?

22-Jun-2025

SciSparc Ltd. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $4 million and a market cap of $3.40 million. Key financial metrics include a negative P/E ratio, a 0.00% dividend yield, and a return on equity of -96.00%.

Overview: <BR>SciSparc Ltd. operates in the Pharmaceuticals & Biotechnology industry and is classified as a micro-cap company.<BR><BR>Financial Snapshot: <BR>Net Profit: -4 Million (Quarterly Results - Dec 2018) <BR>Market Cap: USD 3.40 Million (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.19 <BR>Return on Equity: -96.00% <BR>Price to Book: 0.42 <BR><BR>Contact Details: <BR>Registrar Address: Not available.

Read More

Is SciSparc Ltd. technically bullish or bearish?

20-Sep-2025

As of August 19, 2025, SciSparc Ltd. shows a mildly bullish trend driven by a monthly MACD, despite bearish signals from weekly indicators and moving averages, indicating a cautious outlook amid significant volatility and underperformance compared to the S&P 500.

As of 19 August 2025, the technical trend for SciSparc Ltd. has changed from bullish to mildly bullish. The current stance is mildly bullish, primarily driven by the monthly MACD indicating mild bullishness, while the weekly MACD remains bearish. The moving averages on a daily basis are bearish, and the weekly KST is also bearish, contributing to a mixed outlook. The stock has shown significant volatility, with a 1-week return of 142.19% compared to the S&P 500's 1.05%, but it has underperformed over longer periods, with a year-to-date return of -38.49% versus the S&P 500's 12.22%. Overall, the indicators suggest a cautious bullish sentiment with underlying bearish pressures.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 1 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.19

stock-summary
Return on Equity

-96.00%

stock-summary
Price to Book

0.15

Revenue and Profits:
Net Sales:
(Quarterly Results - Dec 2018)
Net Profit:
-4 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-21.97%
0%
-21.97%
6 Months
-73.94%
0%
-73.94%
1 Year
-62.78%
0%
-62.78%
2 Years
-98.85%
0%
-98.85%
3 Years
55.36%
0%
55.36%
4 Years
-99.95%
0%
-99.95%
5 Years
0%
0%
0.0%

SciSparc Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
-210.45%
EBIT to Interest (avg)
-3.74
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.19
Sales to Capital Employed (avg)
0
Tax Ratio
0.72%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.43
EV to EBIT
-0.23
EV to EBITDA
-0.23
EV to Capital Employed
0.30
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-129.71%
ROE (Latest)
-96.00%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
No Trend
Mildly Bullish
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'18 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2018 is 0.00% vs 0.00% in Dec 2017",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2018 is -44.44% vs -575.00% in Dec 2017",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'18",
        "Dec'17",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-3.00",
          "val2": "-2.60",
          "chgp": "-15.38%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-3.90",
          "val2": "-2.70",
          "chgp": "-44.44%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -55.17% vs 123.08% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -27.12% vs -126.92% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1.30",
          "val2": "2.90",
          "chgp": "-55.17%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-6.80",
          "val2": "-5.20",
          "chgp": "-30.77%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1.20",
          "val2": "0.10",
          "chgp": "-1,300.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-7.50",
          "val2": "-5.90",
          "chgp": "-27.12%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-5,545.20%",
          "val2": "-2,005.20%",
          "chgp": "-354.00%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'18 - YoYstock-summary
Dec'18
Dec'17
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-3.00
-2.60
-15.38%
Interest
0.10
0.00
Exceptional Items
-1.10
0.00
Consolidate Net Profit
-3.90
-2.70
-44.44%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
Net Sales

YoY Growth in quarter ended Dec 2018 is 0.00% vs 0.00% in Dec 2017

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2018 is -44.44% vs -575.00% in Dec 2017

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
1.30
2.90
-55.17%
Operating Profit (PBDIT) excl Other Income
-6.80
-5.20
-30.77%
Interest
0.00
0.00
Exceptional Items
-1.20
0.10
-1,300.00%
Consolidate Net Profit
-7.50
-5.90
-27.12%
Operating Profit Margin (Excl OI)
-5,545.20%
-2,005.20%
-354.00%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is -55.17% vs 123.08% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -27.12% vs -126.92% in Dec 2023

stock-summaryCompany CV
About SciSparc Ltd. stock-summary
stock-summary
SciSparc Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available